99 related articles for article (PubMed ID: 3311974)
1. Successful pancreatic allografts in combination with bone marrow transplantation in mice.
Iwai H; Yasumizu R; Sugiura K; Inaba M; Kumazawa T; Good RA; Ikehara S
Immunology; 1987 Nov; 62(3):457-62. PubMed ID: 3311974
[TBL] [Abstract][Full Text] [Related]
2. Long-term (>1 year) analyses of chimerism and tolerance in mixed allogeneic chimeric mice using normal mouse combinations.
Hayashi H; Toki J; Zhexiong L; Sugiura K; Inoue K; Ikehara S
Stem Cells; 2000; 18(4):273-80. PubMed ID: 10924093
[TBL] [Abstract][Full Text] [Related]
3. Successful liver allografts in mice by combination with allogeneic bone marrow transplantation.
Nakamura T; Good RA; Yasumizu R; Inoue S; Oo MM; Hamashima Y; Ikehara S
Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4529-32. PubMed ID: 3520575
[TBL] [Abstract][Full Text] [Related]
4. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
[TBL] [Abstract][Full Text] [Related]
5. Long-term immunologic tolerance induction in chimeric mice after bone marrow transplantation across major histocompatibility barriers: persistent or redeveloping immunologic responsiveness after prolonged survival.
Sugiura K; Yasumizu R; Iwai H; Inaba MM; Toki J; Ogura M; Hara I; Good RA; Ikehara S
Thymus; 1991 Nov; 18(3):137-53. PubMed ID: 1838450
[TBL] [Abstract][Full Text] [Related]
6. Induction of prolonged tolerance to third-party skin grafts following fully allogeneic bone marrow transplantation in mice.
Levite M; Reisner Y
Transplantation; 1993 Mar; 55(3):633-8. PubMed ID: 8456484
[TBL] [Abstract][Full Text] [Related]
7. Development of insulin-dependent diabetes mellitus in [(NOD + BALB/c) --> NOD] mixed allogeneic bone marrow chimeras.
Takao F; Yasumizu R; Than S; Ohnishi-Inoue Y; Sigiura K; Inaba M; Ikehara S
Immunobiology; 1995 Nov; 194(4-5):376-89. PubMed ID: 8749231
[TBL] [Abstract][Full Text] [Related]
8. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
Peeler JS; Niederkorn JY
J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow transplantation combined with mesenchymal stem cells induces immune tolerance without cytotoxic conditioning.
Wang Y; Liu J; Xu C; Zhang W; Bai L; Li N; Liu Y; Wang Y; Su Y; Hu D
J Surg Res; 2011 Nov; 171(1):e123-31. PubMed ID: 21920556
[TBL] [Abstract][Full Text] [Related]
10. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
[TBL] [Abstract][Full Text] [Related]
11. In vivo administration of interleukin-6 in murine allogeneic bone marrow chimeras: early and delayed enhancement of hematopoiesis accompanied with split tolerance but not with graft-versus-host disease.
Imamura M; Hashino S; Kobayashi H; Tanaka J; Imai K; Han M; Fujii Y; Kobayashi M; Higa T; Kasai M
Immunobiology; 1994 Jun; 190(4-5):346-67. PubMed ID: 7982720
[TBL] [Abstract][Full Text] [Related]
12. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
[TBL] [Abstract][Full Text] [Related]
13. Treatment of systemic and organ-specific autoimmune disease in mice by allogeneic bone marrow transplantation.
Ikehara S; Nakamura T; Sekita K; Muso E; Yasumizu R; Ohtsuki H; Hamashima Y; Good RA
Prog Clin Biol Res; 1987; 229():131-46. PubMed ID: 3299389
[TBL] [Abstract][Full Text] [Related]
14. Methyl-Guanine-Methyl-Transferase Transgenic Bone Marrow Transplantation Allows N,N-bis(2-chloroethyl)-Nitrosourea Driven Donor Mixed-Chimerism Without Graft-Versus-Host Disease, and With Donor-Specific Allograft Tolerance.
Hu M; Kramer B; Zhang GY; Wang YM; Watson D; Howden B; McCowage G; Alexander IE; Gunning P; Alexander SI
Transplantation; 2015 Dec; 99(12):2476-84. PubMed ID: 26177088
[TBL] [Abstract][Full Text] [Related]
15. Alpha beta TCR+ T cells play a nonredundant role in the rejection of heart allografts in mice.
Exner BG; Que X; Mueller YM; Domenick MA; Neipp M; Ildstad ST
Surgery; 1999 Aug; 126(2):121-6. PubMed ID: 10455873
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow transplantation across major histocompatability barriers in mice. III. Treatment of donor grafts with monoclonal antibodies directed against Lyt determinants.
Vallera DA; Soderling CC; Kersey JH
J Immunol; 1982 Feb; 128(2):871-5. PubMed ID: 6172513
[TBL] [Abstract][Full Text] [Related]
17. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
[TBL] [Abstract][Full Text] [Related]
18. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
Colson YL; Zadach K; Nalesnik M; Ildstad ST
Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
[TBL] [Abstract][Full Text] [Related]
19. Strain difference in the radiosensitivity of immunocompetent cells and its influence on the residual host-vs-graft reaction in lethally irradiated mice grafted with semiallogeneic bone marrow.
Sado T; Kamisaku H; Kubo E
J Immunol; 1985 Feb; 134(2):704-10. PubMed ID: 3880789
[TBL] [Abstract][Full Text] [Related]
20. Facilitation of hematopoietic recovery by bone grafts with intra-bone marrow-bone marrow transplantation.
Song C; Hisha H; Wang X; Li Q; Li M; Cui W; Guo K; Okazaki S; Mizokami T; Kato J; Cui Y; Feng W; Zhang Y; Shi M; Inaba M; Fan H; Ikehara S
Immunobiology; 2008; 213(6):455-68. PubMed ID: 18514748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
